Estrella Immunopharma, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
ESLA, ESLAW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5858 Horton Street, Suite 370, Emeryville, California

There are no Buy or Sell transactions made by insiders since 7/16/2023

Estrella Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Owl Creek Asset Management, L.P. 10%+ Owner Sep 29, 2023
TradeUP Acquisition Sponsor LLC Former 10% owner Sep 29, 2023
James Long Former Director Sep 29, 2023
Weston Twigg Former Director Sep 29, 2023
Tao Jiang Former Director Sep 29, 2023
Jiandong Xu Chief Financial Officer Sep 29, 2023
Eureka Therapeutics, Inc. 10%+ Owner Sep 29, 2023
Xuejun Janelle Wu Director Sep 29, 2023
Cheng Liu Chief Executive Officer, Director Sep 29, 2023
Pei Xu Director Sep 29, 2023
Weiguang Yang Former Co-CEO and Director Sep 29, 2023
Jianwei Li Former Co-CEO and Director Sep 29, 2023
Luqi Wen Former CFO Sep 29, 2023
Fan Wu Director Sep 29, 2023
Marsha Roberts Director Sep 29, 2023

Recent Insider Transactions by Companies or Individuals for Estrella Immunopharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership